A detailed history of Atria Wealth Solutions, Inc. transactions in Nutri Band Inc. stock. As of the latest transaction made, Atria Wealth Solutions, Inc. holds 10,934 shares of NTRB stock, worth $67,462. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,934
Previous 10,934 -0.0%
Holding current value
$67,462
Previous $49,000 20.41%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

SELL
$1.93 - $3.02 $3,153 - $4,934
-1,634 Reduced 13.0%
10,934 $25,000
Q2 2023

Aug 03, 2023

BUY
$2.04 - $3.86 $25,638 - $48,512
12,568 New
12,568 $37,000
Q1 2023

May 10, 2023

BUY
$2.9 - $4.96 $36,447 - $62,337
12,568 New
12,568 $41,000
Q4 2022

Feb 13, 2023

SELL
$3.53 - $4.5 $40,912 - $52,155
-11,590 Closed
0 $0
Q3 2022

Nov 14, 2022

BUY
$3.49 - $7.83 $40,449 - $90,749
11,590 New
11,590 $42,000

Others Institutions Holding NTRB

About NutriBand Inc.


  • Ticker NTRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 7,803,260
  • Market Cap $48.1M
  • Description
  • Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...
More about NTRB
Track This Portfolio

Track Atria Wealth Solutions, Inc. Portfolio

Follow Atria Wealth Solutions, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.